About Clinical Center of Serbia
Универзитетски клинички центар Србије је један од здравствених центара који се налази на општини Савски венац у Београду, Србија. Састоји се из преко 30 клиника и центара који су специјализовани за психијатрију, кардиологију, ендокринологију, гинекологију, урологију и др.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Clinical Center of Serbia
During the past decade, Clinical Center of Serbia conducted 105 clinical trials. In the 10-year time frame, 105 clinical trials started and 55 clinical trials were completed, i.e. on
average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 34 clinical trials were completed. i.e. 82.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
2014-02-07
Active, not recruiting
2,012
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
2015-07-01
2019-08-26
Completed
518
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
2016-07-07
2023-10-31
Active, not recruiting
333
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clinical Center of Serbia" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Clinical Centre of Serbia" with 11 trials
sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 6 trials sponsored and "Boehringer Ingelheim"
with 6 trials sponsored. Other sponsors include 122 different institutions and
companies that sponsored additional 99 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Center of Serbia"
#1 collaborator was "Clinical Centre of Serbia" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Medtronic" with 3 trials as a collaborator, "Military Medical Academy, Belgrade, Serbia" with 3 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 110 different institutions and companies that were
collaborators in the rest 117 trials.
Clinical Trials Conditions at Clinical Center of Serbia
According to Clinical.Site data, the most researched conditions in "Clinical Center of Serbia" are
"Coronary Artery Disease" (6 trials), "Crohn's Disease" (6 trials), "Multiple Sclerosis" (6 trials), "Depressive Disorder, Major" (5 trials) and "Acromegaly" (4 trials). Many other conditions were trialed in "Clinical Center of Serbia" in a lesser frequency.
Clinical Trials Intervention Types at Clinical Center of Serbia
Most popular intervention types in "Clinical Center of Serbia" are "Drug" (124 trials), "Device" (22 trials), "Biological" (11 trials), "Other" (11 trials) and "Procedure" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (58 trials), "Carboplatin" (6 trials), "Pemetrexed" (5 trials), "placebo" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Center of Serbia
The vast majority of trials in "Clinical Center of Serbia" are
165 trials for "All" genders and 3 trials for "Male" genders.
Clinical Trials Status at Clinical Center of Serbia
Currently, there are NaN active trials in "Clinical Center of Serbia".
undefined are not yet recruiting,
29 are recruiting,
21 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 93 completed trials in Clinical Center of Serbia,
undefined suspended trials,
and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Center of Serbia, 4 "Phase 1"
clinical trials were conducted, 33 "Phase 2" clinical
trials and 89 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 17 trials that are defined as “Not Applicable".